Literature DB >> 2047940

Factors influencing transient expression in cytotoxic T cells following DEAE dextran-mediated gene transfer.

C J Frégeau1, R C Bleackley.   

Abstract

A number of transfection protocols have been tested for the introduction of exogenous DNA into cytotoxic T cells. These included electroporation, lipofection, calcium phosphate coprecipitation, polybrene-assisted gene transfer, and DEAE dextran-mediated transfer. Only the latter gave significant and reproducible transfection efficiencies coupled with low toxicity. The DEAE dextran protocol was optimized for the transfection of a transcription reporter construct pRSVcat into a cloned cytotoxic cell line. Among the parameters investigated were cell density, amount of input DNA, concentration of DEAE dextran, DNA adsorption time, temperature, use of permeabilization and expression facilitators, and recovery time. The optimized protocol was then used to demonstrate the presence of cis-acting regulatory regions in the 5'-flanking sequences of two cytotoxic cell-specific serine protease genes and, in addition, was shown to be applicable to other cloned T-cell lines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047940     DOI: 10.1007/bf01232820

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  3 in total

1.  Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate.

Authors:  C J Frégeau; C D Helgason; R C Bleackley
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

2.  An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene.

Authors:  C L Miller; R Garner; V Paetkau
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

3.  Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells.

Authors:  M Cassan; N Delaunay; C Vaquero; J P Rousset
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.